Progyny (PGNY) vs Viemed Healthcare (VMD)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Progyny (PGNY) has outperformed Viemed Healthcare (VMD) over the past year, gaining 37.8% versus a gain of 36.4%. Over five years, VMD leads with a +62.4% price change compared with -50.8% for PGNY. Progyny is the larger company by market cap ($2.11 billion vs $356.9 million), about 5.9 times the size.
On valuation, Progyny trades at a lower forward P/E (11.9x vs 23.4x for Viemed Healthcare).
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | PGNY | VMD |
|---|---|---|
| Share price | $27.55 | $9.37 |
| Market cap | $2.11B | $356.89M |
| 1-day change | +6.33% | +0.43% |
| YTD return | +7.28% | +26.11% |
| 1-year return | +37.75% | +36.39% |
| 5-year return | -50.79% | +62.39% |
| P/E ratio (TTM) | 29.95 | 26.03 |
| Forward P/E | 11.88 | 23.43 |
| EPS (TTM) | $0.92 | $0.36 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $33.07 | $12.61 |
| 52-week low | $16.10 | $6.05 |
| Distance from 52-week high | -16.68% | -25.69% |
| Analyst consensus | none | buy |
| Avg. price target upside | +24.94% | +33.40% |
| Average volume | 1.13M | 354.17K |
| Shares outstanding | 76.73M | 38.09M |
| Employees | 835 | 1,438 |
| Sector | Health Care | Healthcare |
| Industry | Misc Health and Biotechnology Services | Medical Devices |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Progyny is about 5.9 times larger than Viemed Healthcare by market value ($2.11B vs $356.89M).
- The two companies sit in different sectors: Progyny in Health Care and Viemed Healthcare in Healthcare.
About Progyny
PGNY stock →Progyny, Inc., a benefits management company, provides fertility, family building, and women's health benefits solutions in the United States. It offers fertility benefits solutions, such as differentiated benefits plan design that includes smart cycle treatment bundle; personalized concierge-style member support services; and a selective network of fertility specialists.
Health Care · Misc Health and Biotechnology Services · 835 employees
About Viemed Healthcare
VMD stock →Viemed Healthcare, Inc., through its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services in the United States. The company provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.
Healthcare · Medical Devices · 1,438 employees
PGNY vs VMD FAQ
Which is bigger, Progyny or Viemed Healthcare?
Progyny (PGNY) is larger, with a market capitalization of $2.11B compared with $356.89M for Viemed Healthcare (VMD).
Which stock has performed better over the past year, PGNY or VMD?
PGNY returned +37.75% over the past 12 months, compared with +36.39% for VMD (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, PGNY or VMD?
VMD has the lower trailing P/E at 26.0, versus 29.9 for PGNY. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Are Progyny and Viemed Healthcare in the same industry?
No. Progyny is in the Health Care sector, while Viemed Healthcare is in Healthcare.